SIMILASAN Difficultés d'avaler glob 15 g

7680509200489 CH-50920 20.01.1.
SIMILASAN Difficultés d'avaler glob 15 g
SIMILASAN Difficultés d'avaler glob 15 g
SIMILASAN Difficultés d'avaler glob 15 g
1 / 3
google

Details

Product number
5092001
CPT
-
Packaging group
15
Unit
g
Composition
guajacum (HAB) D3 7.000 mg, guajacum (HAB) D6 2.000 mg, guajacum (HAB) D12 1.000 mg, calcii carbonas, xylitolum, ad globulos pro 1 g corresp. 70-90 granula homoeopathica imbuta.

Articles (1)

Similasan Schluckweh, Globuli
Globuli
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/10/2022
Patient information leaflet
Français
26/10/2022
Patient information leaflet
Italien
26/10/2022

Detailed composition

Substance Quantity Type Category
(N/A)
7.0 MG Substance Wirkstoff (Principe actif)
(N/A)
2.0 MG Substance Wirkstoff (Principe actif)
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
50920
Drug name
Similasan Schluckweh, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
14/08/1991
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Schluckbeschwerden und stechenden Halsschmerzen

Packaging details

Description (FR)
SIMILASAN Difficultés d'avaler glob 15 g
Description (DE)
SIMILASAN Schluckweh Glob 15 g
Market launch
14/08/1991
Narcotic (BTM)
No

Other packaging sizes